Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-11 4:4:36 am | Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference | BusinessWire |
| 2024-02-28 4:0:0 am | Can-Fite Broadens its Strong Intellectual Property (IP) for NASH: Received Patent Allowance in Canada | Business Wire |
| 2024-01-30 4:0:0 am | Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication | Business Wire |
| 2024-01-29 4:0:0 am | Can-Fite: Top Scientific Journal Published Positive Data from the COMFORT-1 Phase III Psoriasis Study | Business Wire |
| 2023-12-20 4:0:0 am | The Anti-Obesity Effect of Can-Fite’s Namodenoson: Molecular Mechanism of Action in Pre-clinical and Human Studies | Business Wire |
| 2023-12-18 4:0:0 am | Can-Fite Received FDA Positive Response to Psoriasis Pediatric Plan | Business Wire |
Please consider a small donation if you think this website provides you with relevant information